BioHarvest Sciences Inc. Files November 2024 6-K Report
Ticker: BHST · Form: 6-K · Filed: Nov 25, 2024
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, company-update
TL;DR
BHSC filed its Nov 6-K, standard foreign issuer report. Nothing major.
AI Summary
BioHarvest Sciences Inc. filed a Form 6-K on November 25, 2024, for the month of November 2024. The company, previously known as Midnight Star Ventures Corp. and CANNA-V-CELL SCIENCES INC., is incorporated in A1 and has its principal executive offices in Vancouver, British Columbia, Canada. This filing is a report of a foreign private issuer.
Why It Matters
This filing provides an update on BioHarvest Sciences Inc.'s status as a foreign private issuer, which is relevant for investors tracking regulatory disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- BIOHARVEST SCIENCES INC. (company) — Registrant
- Midnight Star Ventures Corp. (company) — Former company name
- CANNA-V-CELL SCIENCES INC. (company) — Former company name
- November 2024 (date) — Reporting period
- November 25, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of November 2024.
What was BioHarvest Sciences Inc. previously named?
BioHarvest Sciences Inc. was formerly known as CANNA-V-CELL SCIENCES INC. and prior to that, Midnight Star Ventures Corp.
Where are BioHarvest Sciences Inc.'s principal executive offices located?
The principal executive offices of BioHarvest Sciences Inc. are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.
Does BioHarvest Sciences Inc. file annual reports under Form 20-F or 40-F?
BioHarvest Sciences Inc. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for BioHarvest Sciences Inc.?
The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, Pharmaceutical Preparations.
Filing Stats: 248 words · 1 min read · ~1 pages · Grade level 15.9 · Accepted 2024-11-25 17:03:46
Filing Documents
- bhsc_6k.htm (6-K) — 15KB
- bhsc_ex991.htm (EX-99.1) — 293KB
- bhsc_ex992.htm (EX-99.2) — 110KB
- bhsc_ex993.htm (EX-99.3) — 6KB
- bhsc_ex994.htm (EX-99.4) — 7KB
- bhscex992_1.jpg (GRAPHIC) — 10KB
- bhscex992_2.jpg (GRAPHIC) — 11KB
- 0001393905-24-000399.txt ( ) — 462KB
Management's Discussion and Analysis for the period ended September 30, 2024
Management's Discussion and Analysis for the period ended September 30, 2024 99.3 Form 52-109FV2 - Certification of Interim Filings - Full Certificate - CEO 99.4 Form 52-109FV2 - Certification of Interim Filings - Full Certificate - CFO
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: November 25, 2024 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary